Journal of Drugs in Dermatology

View more issues:

Articles in Feb, 2008 issue of Journal of Drugs in Dermatology

• Clarification: 510k is Premarket Notification; it provides no patent or FDA approval
  by Craig G. Burkhart
• Lisinopril-induced erythroderma in an 85-year-old male
  by S.E. Broski
• Efficacy and safety of azithromycin SR compared with minocycline in acne
• A clinical study of curcuminoids in the treatment of oral lichen planus
• New developments in topical antimicrobial therapy for acne
  by James Leyden
• A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin
  by Jerry L. McCullough
• Bosentan in metastatic melanoma
  by Marissa Heller
• Imiquimod in children with plaque morphea
• Topical tazarotene in treating patients with basal cell skin cancer and basal cell nevus syndrome
• Upcoming dermatology meetings
• Treatment of hyperkeratosis with Kerafoam emollient foam to assess effectiveness and safety within a clinical setting: a case study report
  by Jay A. Goldstein
• Study to compare the acne relapse rate of oral minocycline to oral minocycline in combination with topical tretinoin, followed by topical tretinoin alone
• Treatment of Cutaneous Lupus Erythematosus with the 595 nm flashlamp pulsed-dye laser
• Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence
  by James Del Rosso
• Early improvement in rhytides and skin laxity following treatment with a combination fractional laser emitting two wavelengths sequentially
  by K. Wade Foster
• Treatment approaches for advanced cutaneous melanoma
  by Jennifer A. Stein
• Efficacy study of montelukast in atopic dermatitis induced by food allergens
• Safety and effectiveness of efalizumab to treat oral lichen planus
• Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging
  by Suzanne Bruce
• Dermabrasion in our practice
  by Ross M. Campbell
• Generic norethindrone acetate and ethinyl estradiol for acne vulgaris
  by Marissa Heller
• Treatment of alopecia areata of the scalp with intradermal injections of Botulinum Toxin A
• Erlotinib in women with squamous cell carcinoma of the vulva
• Visible light photopatch testing of common photocontactants in female Filipino adults with and without melasma: a cross-sectional study
  by Vermen M. Verallo-Rowell
• European union approves Humira®
  by Marissa Heller
• A pilot study of etanercept in dermatomyositis
• Complete lymph node dissection or observation in treating patients with localized melanoma and sentinel node metastasis who have undergone sentinel lymphadenectomy
• Letter from the guest editors
  by Ronald L. Moy
• Folliculotropic mycosis fungoides responding to bexarotene gel
  by Hobart W. Walling
• Epicream versus Elidel for treatment of mild to moderate atopic dermatitis
• A study to evaluate the safety and effectiveness of etanercept in treating lichen planus on the oral mucosa or skin
• The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure
  by Jouni Uitto
• Photopneumatic technology for the treatment of acne vulgaris
  by Ava T. Shamban
• Gentamicin topical for diabetic foot ulcers
  by Marissa Heller
• UVA1 light for scleroderma and similar conditions
• Intron-A/Aldara combination therapy for BCC
• Reductions in thigh and infraumbilical circumference following treatment with a novel device combining ultrasound, suction, and massage
  by K. Wade Foster
• Diclofenac sodium topical gel for osteoarthritis
  by Marissa Heller
• The effects of probiotics in atopic dermatitis
• Pimecrolimus cream for oral lichen planus
• Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures
  by Suzanne Bruce
• Fractional photothermolysis
  by Sean A. Sukal
• FDA warning for carbamazepine and skin reactions
  by Marissa Heller
• Alefacept in patients with severe scalp alopecia areata
• Single-blind study determining the efficacy of Polypodium leucotomos extract supplement in decreasing UVA premutagenic and photoaging markers
• Skin through the ages: state-of-the-art options for the topical treatment of acne, photodamage, and aging